136 related articles for article (PubMed ID: 11141479)
41. LRP2 contributes to planar cell polarity-dependent coordination of motile cilia function.
Bunatyan L; Margineanu A; Boutin C; Montcouquiol M; Bachmann S; Ilsø Christensen E; Willnow TE; Christ A
Cell Tissue Res; 2023 May; 392(2):535-551. PubMed ID: 36764939
[TBL] [Abstract][Full Text] [Related]
42. HAS2-Ezrin-ER axis plays a role in acquired antiestrogen resistance of ER-positive breast cancer.
Sun X; Tang F; Guo Q; Liu Y; He Y; Du Y; Gao F; Zhang G; Yang C
Front Pharmacol; 2022; 13():1031487. PubMed ID: 36386154
[TBL] [Abstract][Full Text] [Related]
43. NHERF1/EBP50 as a Target for Modulation of MRP Function in HepG2 Cells.
Kawase A; Hirosoko M; Sugihara Y; Koyama Y; Fukae A; Shimada H; Iwaki M
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33800412
[TBL] [Abstract][Full Text] [Related]
44. MINDIN Exerts Protumorigenic Actions on Primary Prostate Tumors via Downregulation of the Scaffold Protein NHERF-1.
Álvarez-Carrión L; Gutiérrez-Rojas I; Rodríguez-Ramos MR; Ardura JA; Alonso V
Cancers (Basel); 2021 Jan; 13(3):. PubMed ID: 33498862
[TBL] [Abstract][Full Text] [Related]
45. Detecting the location and significance of Ezrin protein expression in hepatocellular carcinoma.
Wang Y; Jiang S; Cao Z; Xie C; Li W; Ma Y; Zhang J; Lin L
Int J Clin Exp Pathol; 2018; 11(1):248-254. PubMed ID: 31938107
[TBL] [Abstract][Full Text] [Related]
46. Prognostic and therapeutic implications of NHERF1 expression and regulation in colorectal cancer.
Leiphrakpam PD; Lazenby AJ; Chowdhury S; Smith LM; Mathiesen M; Brattain MG; Wang J; Black JD; Are C
J Surg Oncol; 2020 Mar; 121(3):547-560. PubMed ID: 31867736
[TBL] [Abstract][Full Text] [Related]
47. Ezrin-Radixin-Moesin Binding Phosphoprotein 50: A Potential Novel Biomarker in Human Papilloma Virus-Associated Head and Neck Squamous Cell Carcinomas.
Shankar A; Crouch DH; Macluskey M
Head Neck Pathol; 2019 Jun; 13(2):188-197. PubMed ID: 29846905
[TBL] [Abstract][Full Text] [Related]
48. β-catenin knockdown promotes NHERF1-mediated survival of colorectal cancer cells: implications for a double-targeted therapy.
Saponaro C; Sergio S; Coluccia A; De Luca M; La Regina G; Mologni L; Famiglini V; Naccarato V; Bonetti D; Gautier C; Gianni S; Vergara D; Salzet M; Fournier I; Bucci C; Silvestri R; Passerini CG; Maffia M; Coluccia AML
Oncogene; 2018 Jun; 37(24):3301-3316. PubMed ID: 29551770
[TBL] [Abstract][Full Text] [Related]
49. NHERF1 Between Promises and Hopes: Overview on Cancer and Prospective Openings.
Centonze M; Saponaro C; Mangia A
Transl Oncol; 2018 Apr; 11(2):374-390. PubMed ID: 29455084
[TBL] [Abstract][Full Text] [Related]
50. NHERF1 together with PARP1 and BRCA1 expression as a new potential biomarker to stratify breast cancer patients.
Mangia A; Scarpi E; Partipilo G; Schirosi L; Opinto G; Giotta F; Simone G
Oncotarget; 2017 Sep; 8(39):65730-65742. PubMed ID: 29029467
[TBL] [Abstract][Full Text] [Related]
51. Role of the PDZ-scaffold protein NHERF1/EBP50 in cancer biology: from signaling regulation to clinical relevance.
Vaquero J; Nguyen Ho-Bouldoires TH; Clapéron A; Fouassier L
Oncogene; 2017 Jun; 36(22):3067-3079. PubMed ID: 28068322
[TBL] [Abstract][Full Text] [Related]
52. β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients.
Schirosi L; Mazzotta A; Opinto G; Pinto R; Graziano G; Tommasi S; Fucci L; Simone G; Mangia A
Oncotarget; 2016 Oct; 7(42):67841-67850. PubMed ID: 27765918
[TBL] [Abstract][Full Text] [Related]
53. NHERF1/EBP50 Suppresses Wnt-β-Catenin Pathway-Driven Intestinal Neoplasia.
Georgescu MM; Gagea M; Cote G
Neoplasia; 2016 Aug; 18(8):512-23. PubMed ID: 27566107
[TBL] [Abstract][Full Text] [Related]
54. NHERF1, a novel GPER associated protein, increases stability and activation of GPER in ER-positive breast cancer.
Meng R; Qin Q; Xiong Y; Wang Y; Zheng J; Zhao Y; Tao T; Wang Q; Liu H; Wang S; Jiang WG; He J
Oncotarget; 2016 Aug; 7(34):54983-54997. PubMed ID: 27448983
[TBL] [Abstract][Full Text] [Related]
55. Deletion of Na+/H+ exchanger regulatory factor 2 represses colon cancer progress by suppression of Stat3 and CD24.
Yoshida M; Zhao L; Grigoryan G; Shim H; He P; Yun CC
Am J Physiol Gastrointest Liver Physiol; 2016 Apr; 310(8):G586-98. PubMed ID: 26867566
[TBL] [Abstract][Full Text] [Related]
56. The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy.
Mangia A; Caldarola L; Dell'Endice S; Scarpi E; Saragoni L; Monti M; Santini D; Brunetti O; Simone G; Silvestris N
Cancer Biol Ther; 2015; 16(8):1140-7. PubMed ID: 26126066
[TBL] [Abstract][Full Text] [Related]
57. Drug Transporters and Na+/H+ Exchange Regulatory Factor PSD-95/Drosophila Discs Large/ZO-1 Proteins.
Walsh DR; Nolin TD; Friedman PA
Pharmacol Rev; 2015 Jul; 67(3):656-80. PubMed ID: 26092975
[TBL] [Abstract][Full Text] [Related]
58. NHERF1/EBP50 is an organizer of polarity structures and a diagnostic marker in ependymoma.
Georgescu MM; Yell P; Mobley BC; Shang P; Georgescu T; Wang SH; Canoll P; Hatanpaa KJ; White CL; Raisanen JM
Acta Neuropathol Commun; 2015 Mar; 3():11. PubMed ID: 25775275
[TBL] [Abstract][Full Text] [Related]
59. Fine Needle Aspiration Cytology: A Tool to Study NHERF1 Expression as a Potential Marker of Aggressiveness in Lung Cancer.
Mangia A; Partipilo G; Schirosi L; Saponaro C; Galetta D; Catino A; Scattone A; Simone G
Mol Biotechnol; 2015 Jun; 57(6):549-57. PubMed ID: 25744438
[TBL] [Abstract][Full Text] [Related]
60. Melasma: a clinical and epidemiological review.
Handel AC; Miot LD; Miot HA
An Bras Dermatol; 2014; 89(5):771-82. PubMed ID: 25184917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
